609
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD

, , , &
Pages 90-94 | Published online: 12 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gabriela Hobbs & Ruben Mesa. (2016) New drugs for myelofibrosis. Expert Opinion on Orphan Drugs 4:5, pages 521-529.
Read now
Samah Alimam & Claire Harrison. (2016) Is there a role for pomalidomide in the treatment of myelofibrosis?. Expert Opinion on Orphan Drugs 4:5, pages 501-509.
Read now

Articles from other publishers (4)

Yujin Li, Shirong Zhu, Weiyi Liu, Jing Ming, Xueying Wang & Xiaomei Hu. (2020) Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to. Annals of Hematology 99:6, pages 1161-1176.
Crossref
Monika Podhorecka, Arkadiusz Macheta, Sylwia Chocholska, Agnieszka Bojarska-Junak, Agnieszka Szymczyk, Aneta Goracy, Anna Dmoszynska & Marek Hus. (2015) Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia. Annals of Hematology 95:3, pages 425-435.
Crossref
Arkadiusz Macheta, Agnieszka Szymczyk & Monika Podhorecka. (2014) Danazol – możliwości wykorzystania w leczeniu chorób hematologicznych. Acta Haematologica Polonica 45:2, pages 184-189.
Crossref
S Tung & D E Spaner. (2012) A role for Danazol in chronic lymphocytic leukemia. Leukemia 26:7, pages 1684-1686.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.